A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer — Stella
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(17 sites) United States
Honor Health, Scottsdale, Arizona Hoag Family Cancer Institute, Newport Beach, California UC Irvine Medical Center, Orange, California Next Oncology - Houston, Houston, Texas UT Health, San Antonio, Texas NEXT Oncology, Fairfax, Virginia Summit Cancer Centers, Spokane, Washington China
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian He'nan Cancer Hospital, Zhengzhou, He'Nan Hu'nan Cancer Hospital, Changsha, Hu'Nan Nanjing Drum Tower Hospital, Nanjing, Jiangsu Liaoning Cancer Hospital, Shenyang, Liaoning Shandong Cancer Hospital, Ji'nan, Shandong Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang Last updated December 2025